메뉴 건너뛰기




Volumn 8, Issue 4, 2015, Pages 6530-6543

Probiotics improve efficacy and tolerability of triple therapy to eradicate helicobacter pylori: A meta-analysis of randomized controlled trials

Author keywords

Adverse events; Eradication; Helicobacter pylori; Probiotics; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; FURAZOLIDONE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROBIOTIC AGENT; RABEPRAZOLE; TETRACYCLINE; YOGHURT;

EID: 84931271522     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (30)

References (49)
  • 2
    • 18044386342 scopus 로고    scopus 로고
    • Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods
    • [2] Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N, Mitov I, Krastev Z. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med Microbiol 2005; 54: 481-483.
    • (2005) J Med Microbiol , vol.54 , pp. 481-483
    • Boyanova, L.1    Gergova, G.2    Nikolov, R.3    Derejian, S.4    Lazarova, E.5    Katsarov, N.6    Mitov, I.7    Krastev, Z.8
  • 3
    • 80053913276 scopus 로고    scopus 로고
    • Alternative therapies for Helicobacter pylori: Probiotics and phytomedicine
    • [3] Vítor JMB, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol 2011; 63: 153-164.
    • (2011) FEMS Immunol Med Microbiol , vol.63 , pp. 153-164
    • Vítor, J.1    Vale, F.F.2
  • 4
    • 84891098758 scopus 로고    scopus 로고
    • Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: A double-blind placebo-controlled randomized clinical trial
    • [4] Emara MH, Mohamed SY, Abdel-Aziz HR. Lactobacillus reuteri in management of Helicobacter pylori infection in dyspeptic patients: a double-blind placebo-controlled randomized clinical trial. Therap Adv Gastroenterol 2014; 7: 4-13.
    • (2014) Therap Adv Gastroenterol , vol.7 , pp. 4-13
    • Emara, M.H.1    Mohamed, S.Y.2    Abdel-Aziz, H.R.3
  • 6
    • 84875336094 scopus 로고    scopus 로고
    • Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: A prospective, randomized, double-blind, placebo-controlled study
    • [6] Navarro-Rodriguez T, Silva FM, Barbuti RC, Mattar R, Moraes-Filho JP, de Oliveira MN, Bogsan CS, Chinzon D, Eisig JN. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol 2013; 13: 56.
    • (2013) BMC Gastroenterol , vol.13 , pp. 56
    • Navarro-Rodriguez, T.1    Silva, F.M.2    Barbuti, R.C.3    Mattar, R.4    Moraes-Filho, J.P.5    De Oliveira, M.N.6    Bogsan, C.S.7    Chinzon, D.8    Eisig, J.N.9
  • 7
  • 9
    • 84870229910 scopus 로고    scopus 로고
    • Randomized control trial: Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication
    • [9] Mirzaee V, Rezahosseini O. Randomized control trial: Comparison of Triple Therapy plus Probiotic Yogurt vs. Standard Triple Therapy on Helicobacter Pylori Eradication. Iran Red Crescent Med J 2012;14: 657-666.
    • (2012) Iran Red Crescent Med J , vol.14 , pp. 657-666
    • Mirzaee, V.1    Rezahosseini, O.2
  • 11
    • 79953222976 scopus 로고    scopus 로고
    • Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori
    • [11] Bekar O, Yilmaz Y, Gulten M. Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food 2011; 14: 344-347.
    • (2011) J Med Food , vol.14 , pp. 344-347
    • Bekar, O.1    Yilmaz, Y.2    Gulten, M.3
  • 16
    • 34547569295 scopus 로고    scopus 로고
    • Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: A prospective randomized placebo-controlled double-blind study
    • [18] Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 2007; 12: 309-316.
    • (2007) Helicobacter , vol.12 , pp. 309-316
    • Cindoruk, M.1    Erkan, G.2    Karakan, T.3    Dursun, A.4    Unal, S.5
  • 17
    • 33750402825 scopus 로고    scopus 로고
    • Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics
    • [19] Ziemniak W. Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics. J Physiol Pharmacol 2006; Suppl 3: 123-141.
    • (2006) J Physiol Pharmacol , pp. 123-141
    • Ziemniak, W.1
  • 18
    • 19544363425 scopus 로고    scopus 로고
    • Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study
    • [20] Myllyluoma E, Veijola L, Ahlroos T, Tynkkynen S, Kankuri E, Vapaatalo H, Rautelin H, Korpela R. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study. Aliment Pharmacol Ther 2005; 21: 1263-1272.
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 1263-1272
    • Myllyluoma, E.1    Veijola, L.2    Ahlroos, T.3    Tynkkynen, S.4    Kankuri, E.5    Vapaatalo, H.6    Rautelin, H.7    Korpela, R.8
  • 20
    • 0036734930 scopus 로고    scopus 로고
    • Impact of supplement with Lactobacillus-and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication
    • [22] Sheu BS, Wu JJ, Lo CY, Wu HW, Chen JH, Lin YS, Lin MD. Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16: 1669-1675.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 1669-1675
    • Sheu, B.S.1    Wu, J.J.2    Lo, C.Y.3    Wu, H.W.4    Chen, J.H.5    Lin, Y.S.6    Lin, M.D.7
  • 25
    • 0021259505 scopus 로고
    • Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
    • [27] Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
    • (1984) Lancet , vol.1 , pp. 1311-1315
    • Marshall, B.J.1    Warren, J.R.2
  • 28
    • 84876918195 scopus 로고    scopus 로고
    • Helicobacter pylori and autoimmune diseases
    • [30] Faria C, Zakout R, Araujo M. Helicobacter pylori and autoimmune diseases. Biomed Pharmacother 2013; 67: 347-349.
    • (2013) Biomed Pharmacother , vol.67 , pp. 347-349
    • Faria, C.1    Zakout, R.2    Araujo, M.3
  • 29
    • 0042825872 scopus 로고    scopus 로고
    • Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori
    • [31] Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, Wu JJ. Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther 2003; 18: 347-353.
    • (2003) Aliment Pharmacol Ther , vol.18 , pp. 347-353
    • Chi, C.H.1    Lin, C.Y.2    Sheu, B.S.3    Yang, H.B.4    Huang, A.H.5    Wu, J.J.6
  • 30
    • 18244409612 scopus 로고    scopus 로고
    • Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. Pylori after failed therapy
    • [32] Kao AW, Cheng HC, Sheu BS, Lin CY, Sheu MJ, Yang HB, Wu JJ. Posttreatment 13C-urea breath test is predictive of antimicrobial resistance to H. pylori after failed therapy. J Gen Intern Med 2005; 20: 139-142.
    • (2005) J Gen Intern Med , vol.20 , pp. 139-142
    • Kao, A.W.1    Cheng, H.C.2    Sheu, B.S.3    Lin, C.Y.4    Sheu, M.J.5    Yang, H.B.6    Wu, J.J.7
  • 31
    • 34547619783 scopus 로고    scopus 로고
    • American College of Gastroenterology guideline on the management of Helicobacter pylori infection
    • [33] Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007; 102: 1808-1825.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1808-1825
    • Chey, W.D.1    Wong, B.C.2
  • 32
    • 0036892319 scopus 로고    scopus 로고
    • A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study
    • [34] Katelaris PH, Forbes GM, Talley NJ, Crotty B. A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology 2002; 123: 1763-1769.
    • (2002) Gastroenterology , vol.123 , pp. 1763-1769
    • Katelaris, P.H.1    Forbes, G.M.2    Talley, N.J.3    Crotty, B.4
  • 33
    • 0037417532 scopus 로고    scopus 로고
    • Quadruple treatments for Helicobacter pylori
    • [35] Mascitelli L, Pezzetta F. Quadruple treatments for Helicobacter pylori. Lancet 2003; 361: 86.
    • (2003) Lancet , vol.361 , pp. 86
    • Mascitelli, L.1    Pezzetta, F.2
  • 34
    • 84899514335 scopus 로고    scopus 로고
    • Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease
    • [36] Rossi G, Pengo G, Caldin M, Palumbo Piccionello A, Steiner JM, Cohen ND, Jergens AE, Suchodolski JS. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease. PLoS One 2014; 9: e94699.
    • (2014) Plos One , vol.9
    • Rossi, G.1    Pengo, G.2    Caldin, M.3    Palumbo Piccionello, A.4    Steiner, J.M.5    Cohen, N.D.6    Jergens, A.E.7    Suchodolski, J.S.8
  • 35
    • 84896918001 scopus 로고    scopus 로고
    • Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model?
    • [37] Wang H, Gong J, Wang W, Long Y, Fu X, Fu Y, Qian W, Hou X. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One 2014; 9: e90153.
    • (2014) Plos One , vol.9
    • Wang, H.1    Gong, J.2    Wang, W.3    Long, Y.4    Fu, X.5    Fu, Y.6    Qian, W.7    Hou, X.8
  • 37
    • 84877798095 scopus 로고    scopus 로고
    • Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: New insight into the probiotics for the gut-liver axis
    • [39] Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T. Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. PLoS One 2013; 8: e63388.
    • (2013) Plos One , vol.8
    • Endo, H.1    Niioka, M.2    Kobayashi, N.3    Tanaka, M.4    Watanabe, T.5
  • 38
    • 84873541202 scopus 로고    scopus 로고
    • Helicobacter pylori is a risk factor for colonic neoplasms
    • [40] Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108: 208-215.
    • (2013) Am J Gastroenterol , vol.108 , pp. 208-215
    • Sonnenberg, A.1    Genta, R.M.2
  • 39
    • 51649083010 scopus 로고    scopus 로고
    • Effects of multispecies probiotic combination on helicobacter pylori infection in vitro
    • [41] Myllyluoma E, Ahonen AM, Korpela R, Vapaatalo H, Kankuri E. Effects of multispecies probiotic combination on helicobacter pylori infection in vitro. Clin Vaccine Immunol 2008; 15: 1472-1482.
    • (2008) Clin Vaccine Immunol , vol.15 , pp. 1472-1482
    • Myllyluoma, E.1    Ahonen, A.M.2    Korpela, R.3    Vapaatalo, H.4    Kankuri, E.5
  • 40
    • 0141793607 scopus 로고    scopus 로고
    • The role of probiotics in the treatment and prevention of Helicobacter pylori infection
    • [42] Hamilton-Miller JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2003; 22: 360-366.
    • (2003) Int J Antimicrob Agents , vol.22 , pp. 360-366
    • Hamilton-Miller, J.M.1
  • 41
    • 33746600634 scopus 로고    scopus 로고
    • Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain
    • [43] Tamura A, Kumai H, Nakamichi N, Sugiyama T, Deguchi R, Takagi A, Koga Y. Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain. J Gastroenterol Hepatol 2006; 21: 1399-1406.
    • (2006) J Gastroenterol Hepatol , vol.21 , pp. 1399-1406
    • Tamura, A.1    Kumai, H.2    Nakamichi, N.3    Sugiyama, T.4    Deguchi, R.5    Takagi, A.6    Koga, Y.7
  • 43
    • 84908330396 scopus 로고    scopus 로고
    • Saccharomyces boulardii expresses neuraminidase activity selective for alpha2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells
    • [45] Sakarya S, Gunay N. Saccharomyces boulardii expresses neuraminidase activity selective for alpha2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells. APMIS 2014; 122: 941-950.
    • (2014) APMIS , vol.122 , pp. 941-950
    • Sakarya, S.1    Gunay, N.2
  • 44
    • 0033948207 scopus 로고    scopus 로고
    • Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice
    • [46] Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Kamiya S. Studies of the effect of Clostridium butyricum on Helicobacter pylori in several test models including gnotobiotic mice. J Med Microbiol 2000; 49: 635-642.
    • (2000) J Med Microbiol , vol.49 , pp. 635-642
    • Takahashi, M.1    Taguchi, H.2    Yamaguchi, H.3    Osaki, T.4    Kamiya, S.5
  • 45
    • 33846012178 scopus 로고    scopus 로고
    • Meta-analysis: The effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy
    • [47] Tong JL, Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2007; 25: 155-168.
    • (2007) Aliment Pharmacol Ther , vol.25 , pp. 155-168
    • Tong, J.L.1    Ran, Z.H.2    Shen, J.3    Zhang, C.X.4    Xiao, S.D.5
  • 46
    • 58149260361 scopus 로고    scopus 로고
    • Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: A systematic review and meta-analysis of randomized-controlled trials
    • [48] Sachdeva A, Nagpal J. Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 2009; 45-53.
    • (2009) Eur J Gastroenterol Hepatol , pp. 45-53
    • Sachdeva, A.1    Nagpal, J.2
  • 47
    • 84871592978 scopus 로고    scopus 로고
    • Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy
    • [49] Wang ZH, Gao QY, Fang JY. Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol 2013; 47: 25-32.
    • (2013) J Clin Gastroenterol , vol.47 , pp. 25-32
    • Wang, Z.H.1    Gao, Q.Y.2    Fang, J.Y.3
  • 48
    • 84871592978 scopus 로고    scopus 로고
    • Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
    • [50] Wang ZH, Gao QY, Fang JY. Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy. J Clin Gastroenterol 2013; 47: 25-32.
    • (2013) J Clin Gastroenterol , vol.47 , pp. 25-32
    • Wang, Z.H.1    Gao, Q.Y.2    Fang, J.Y.3
  • 49
    • 84893164758 scopus 로고    scopus 로고
    • Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: Evidence from a meta-analysis
    • [51] Zheng X, Lyu L, Mei Z. Lactobacillus-containing probiotic supplementation increases Helicobacter pylori eradication rate: Evidence from a meta-analysis. Rev Esp Enferm Dig 2013; 105: 445-453.
    • (2013) Rev Esp Enferm Dig , vol.105 , pp. 445-453
    • Zheng, X.1    Lyu, L.2    Mei, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.